Cefepime-enmetazobactam may be more effective than piperacillin-tazobactam in treating complicated UTI and acute pyelonephritis caused by organisms that produce extended-spectrum β-lactamases (ESBL), investigators suggested.
In a study of 121 patients with lupus nephritis on dialysis, 26.4% experienced an SLE flare at a median of 17 months after dialysis initiation.
Both potassium binders effectively lowered serum potassium levels in patients on hemodialysis meeting hyperkalemia definitions, compared with no treatment, investigators reported.
Clear management guidelines are needed for AKI during immune checkpoint inhibitor therapy, according to investigators.
Incremental hemodialysis appears as safe as conventional hemodialysis with respect to death risk in appropriately selected patients, with data from randomized controlled trials suggesting that incremental hemodialysis reduced the likelihood of hospitalization.
Data are from the first randomized clinical trial evaluating whether prophylactic antibiotics are needed for transperineal prostate biopsy.
Risk of fracture at specific sites differed by cause of kidney failure, investigators found.
Of 19 patients with high-risk NMIBC treated with local docetaxel, 14 had prior BCG exposure.
In the first 5 years after dialysis initiation, women had a 6% increased risk for death compared with men in adjusted analyses.
Study included a large, contemporary cohort of patients with T1a renal cell carcinoma undergoing partial nephrectomy or local tumor destruction.
